Case report:: successful treatment of alveolar hypoventilation due to dermatomyositis with anti-tumour necrosis factor-alpha
Case report:: successful treatment of alveolar hypoventilation due to dermatomyositis with anti-tumour necrosis factor-alpha
复制标题
DOI:
10.1093/rheumatology/keh226
复制
发表时间:
2004-07-01
期刊:
影响因子:
5.5
通讯作者:
Büyükkidan, B
中科院分区:
文献类型:
--
作者:
Korkmaz, C;Temiz, G;Büyükkidan, B
SIR, Respiratory complications can be seen in the course of dermatomyositis (DM), but alveolar hypoventilation due to respiratory muscle weakness has only been infrequently reported [1, 2]. Alveolar hypoventilation can be resistant to conventional agents, which may result in either death or dependence on home mechanical ventilation [2, 3].We present a patient with DM with alveolar hypoventilation who failed to respond to a combined immunosuppressive treatment. The initiation of anti-tumour necrosis factor-alpha (anti-TNF-a) resulted in improvement in her ventilatory insufficiency. A 19-yr-old girl was admitted to hospital with a 1-month history of having difficulty in swallowing apart from dysphonia. Physical examination disclosed heliotrope rashes and periungual erythema. Her proximal muscle power was 2/5. Her erythrocyte sedimentation rate (ESR) was 28mm/h. Serum levels of muscle enzymes were increased: creatinine kinase (CK) 3050 U/l (normal 16–190), lactate dehydrogenase (LDH) 1257U/l (normal 240–480), aspartate aminotransferase (AST) 284U/l (normal 0–40), alanine